Cargando…

Copper transport system and response to ovarian cancer chemotherapy

Detalles Bibliográficos
Autores principales:	Tecza, Karolina, Pamula-Pilat, Jolanta, Kolosza, Zofia, Grzybowska, Ewa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4674894/ http://dx.doi.org/10.1186/1897-4287-13-S2-A9

Ejemplares similares

Genetic polymorphisms and ovarian cancer risk and response to paclitaxel/cisplatin chemotherapy
por: Tecza, Karolina, et al.
Publicado: (2015)

Genetic polymorphisms, efficiency and toxicity of cancer chemotherapy
por: Tecza, Karolina, et al.
Publicado: (2015)

Genetic polymorphisms and gene-dosage effect in ovarian cancer risk and response to paclitaxel/cisplatin chemotherapy
por: Tecza, Karolina, et al.
Publicado: (2015)

Pharmacogenetics of FAC chemotherapy side effects in breast cancer patients
por: Tecza, Karolina, et al.
Publicado: (2015)

Spectrum of tumors in the families with Hereditary Breast Ovarian Cancer syndrome carrying germline mutations in BRCA1 and 2 genes
por: Budryk, M, et al.
Publicado: (2012)

Genetic polymorphisms and response to 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients
por: Tecza, Karolina, et al.
Publicado: (2016)

Pharmacogenetics of toxicity of 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients
por: Tecza, Karolina, et al.
Publicado: (2018)

Genetic 3′UTR variations and clinical factors significantly contribute to survival prediction and clinical response in breast cancer patients
por: Pamuła-Piłat, Jolanta, et al.
Publicado: (2020)

Clinicopathological characteristics of breast cancer patients with NOD2 mutation according to age
por: Huszno, Joanna, et al.
Publicado: (2020)

High-throughput genotyping of a common deletion polymorphism disrupting the TRY6 gene and its association with breast cancer risk
por: Wagner, Kerstin, et al.
Publicado: (2007)

Overall survival analysis of > 65-year-old patients with breast cancer based on their molecular, clinicopathological and laboratory factors
por: Huszno, Joanna, et al.
Publicado: (2022)

Gene Expression Analysis in Ovarian Cancer – Faults and Hints from DNA Microarray Study
por: Lisowska, Katarzyna Marta, et al.
Publicado: (2014)

The putative oncogene, CRNDE, is a negative prognostic factor in ovarian cancer patients
por: Szafron, Lukasz Michal, et al.
Publicado: (2015)

Functional Impact of Sequence Alterations Found in BRCA1 Promoter/5'UTR Region in Breast/Ovarian Cancer Families from Upper Silesia, Poland
por: Pamuła, Jolanta, et al.
Publicado: (2006)

Identification of a genetic variant associated with treatment outcome in ovarian cancer: the potential role of cholesterol metabolism as a determinant of response to chemotherapy
por: Chenevix-Trench, Georgia, et al.
Publicado: (2012)

Copper as diagnostic marker of cancers
por: Muszyńska, Magdalena, et al.
Publicado: (2015)

Prevalence of the most frequent BRCA1 mutations in Polish population
por: Brozek, Izabela, et al.
Publicado: (2011)

Meeting abstracts from the Annual Conference on Hereditary Cancers 2015: Szczecin, Poland. 24-25 September, 2015
por: Thompson, Ella R., et al.
Publicado: (2017)

Selenium and cancer – what have we learned from epidemiology and molecular epidemiology studies?
por: Jablonska, Ewa, et al.
Publicado: (2015)

Predicting breast cancer response to chemotherapy using quantitative magnetic resonance (MR) imaging
por: Turnbull, LW, et al.
Publicado: (2002)

The risk factors of toxicity during chemotherapy and radiotherapy in breast cancer patients according to the presence of BRCA gene mutation
por: Huszno, Joanna, et al.
Publicado: (2015)

OPCML, a novel systems regulator of tyrosine kinase signaling in ovarian and other cancers
por: Gabra, H
Publicado: (2012)

Does emergency transportation induce a stress-response in probationers
por: Doerges, V, et al.
Publicado: (1999)

The Australian Ovarian Cancer Study
por: Traficante, N, et al.
Publicado: (2012)

Pathological diagnosis of ovarian cancer
por: High, Hilda, et al.
Publicado: (2012)

Complete pathological response in patients with locally advanced cancer of breast and positive Her2/neu with neoadjuvant chemotherapy
por: Cedeño, Heidy, et al.
Publicado: (2007)

Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients
por: Thompson, ER, et al.
Publicado: (2012)

The NBD-NBD interface is not the sole determinant for transport in ABC transporters
por: Dönmez, Yaprak, et al.
Publicado: (2012)

Deciphering structural rearrangements during transport process in the bacterial transporter GltPh, homolog to mammalian glutamate transporter
por: Venkatesan, SanthoshKannan, et al.
Publicado: (2012)

BRCA1 founder mutations and ovarian cancer in Belarus
por: Savanevich, A, et al.
Publicado: (2015)

Reclassifying ovarian cancer: origins, subtypes and resistance to therapy
por: Bowtell, DDL
Publicado: (2012)

Selenium (Se) and the risk of breast, ovarian and prostate cancers
por: Jaworska, Katarzyna, et al.
Publicado: (2012)

Calmodulin kinase II regulates amphetamine-induced reverse transport in the dopamine transporter: implications for the importance of the dopamine transporter in Angelman syndrome
por: Steinkellner, Thomas, et al.
Publicado: (2010)

An association study between various monoamine transporter gene polymorphisms and treatment response to mirtazapine in major depression
por: Choi, Hong
Publicado: (2010)

Our experience in using magnetic resonance imaging (MRI) as an adjunct to mammography and ultrasound in assessing response to neoadjuvant chemotherapy
por: Dall, B, et al.
Publicado: (2002)

Cancer predisposing BARD1 mutations in breast-ovarian cancer families
por: Ratajska, Magdalena, et al.
Publicado: (2012)

High-dose chemotherapy in breast cancer: Dutch randomized studies
por: Rodenhuis, S, et al.
Publicado: (2001)

Calmodulin kinase II regulates amphetamine-induced reverse transport in dopamine and serotonin transporters
por: Steinkellner, Thomas, et al.
Publicado: (2012)

Transport of the high-risk neonate
por: Messner, Hubert, et al.
Publicado: (2015)

Simulation on neonatal stabilization and transport
por: Cuttano, Armando, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_04m813srnpls92phce553s9t5r